Standard Molecular Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 6
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $1.44M
Latest Deal Amount
  • Investors
  • 1

Standard Molecular General Information

Description

Developer of a purpose-engineered genomic testing system designed to access discrete genomic data. The company's system offers personalized medicine, genetic testing, cancer genomics and presents unique opportunities to clinicians, enabling clinicians in diagnostic and therapeutic innovation for workflow optimization, HL7/XML reporting of discrete results, and data integration with existing information systems in the laboratory and across the health system.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Monitoring Equipment
Biotechnology
Primary Office
  • 1 Broadway
  • 14th Floor
  • Cambridge, MA 02142
  • United States
+1 (860) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Standard Molecular Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 09-Apr-2018 $1.44M 00.000 00.000 Completed Generating Revenue
1. Early Stage VC 08-Apr-2016 00000 00000 00.00 Completed Generating Revenue
To view Standard Molecular’s complete valuation and funding history, request access »

Standard Molecular Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Seed 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view Standard Molecular’s complete cap table history, request access »

Standard Molecular Executive Team (5)

Name Title Board Seat Contact Info
Jeffrey Sopko President & Chief Executive Officer
Jim D'Augustine Vice President, Engineering
David Artz MD Co-Founder, Chief Medical Officer & Board Member
You’re viewing 3 of 5 executive team members. Get the full list »

Standard Molecular Board Members (5)

Name Representing Role Since
Adam Lessler MD Evidity Health Capital Board Member 000 0000
Andrew Smith Standard Molecular Board Member 000 0000
David Artz MD Standard Molecular Co-Founder, Chief Medical Officer & Board Member 000 0000
Paul Enever Self Member Board of Directors 000 0000
Paul Enever Ph.D Evidity Health Capital Chairman 000 0000
To view Standard Molecular’s complete board members history, request access »

Standard Molecular Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Standard Molecular Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Evidity Health Capital Growth/Expansion Minority 000 0000 000000 0
To view Standard Molecular’s complete investors history, request access »